Conservative starting doses would be essential: Initial phase : Cagrilintide 0.3 mg + Tirzepatide 2.5 mg weekly Escalation : Increase cagrilintide by 0.3-0.6 mg every 4 weeks Tirzepatide adjustment : Maintain or modestly increase based on tolerance Monitoring : Close observation for cumulative GI effects This remains speculative, as no published trials have examined this specific combination
H., Pang, J
S6.B: SPECIFIED STIMULANTS INCLUDING, BUT NOT LIMITED TO: 2-phenylpropan-1-amine (-methylphenylethylamine, BMPEA) 3-Methylhexan-2-amine (1,2-dimethylpentylamine) 4-Fluoromethylphenidate 4-Methylhexan-2-amine (1,3-dimethylamylamine, 1,3 DMAA, methylhexaneamine) 4-Methylpentan-2-amine (1,3-dimethylbutylamine) 5-Methylhexan-2-amine (1,4-dimethylamylamine, 1,4-dimethylpentylamine, 1,4-DMAA) Benzfetamine Cathine** Cathinone and its analogues, e.g
This would be my first actual injection that I would administer as a nurse in training, and I must say, at the time it was quite nerve racking